CCR7 Deficiency Enhances Hematopoietic Stem Cell And Myeloid Progenitor Cell Proliferation And Ameliorates Susceptibility To Invasive Pulmonary Aspergillosis Following Hematopoietic Stem Cell Transplantation

Author(s):  
Adam Hartigan ◽  
John Westwick ◽  
Gabor Jarai ◽  
Cory Hogaboam
2014 ◽  
Vol 111 (8) ◽  
pp. 3122-3127 ◽  
Author(s):  
S. J. Baker ◽  
A. Ma'ayan ◽  
Y. K. Lieu ◽  
P. John ◽  
M. V. R. Reddy ◽  
...  

2021 ◽  
Vol 7 (9) ◽  
pp. 753
Author(s):  
Patcharin Thammasit ◽  
Jirapas Sripetchwandee ◽  
Joshua D. Nosanchuk ◽  
Siriporn C. Chattipakorn ◽  
Nipon Chattipakorn ◽  
...  

Invasive pulmonary aspergillosis is a frequent complication in immunocompromised individuals, and it continues to be an important cause of mortality in patients undergoing hematopoietic stem cell transplantation. In addition to antifungal therapy used for mycoses, immune-modulatory molecules such as cytokines and chemokines can modify the host immune response and exhibit a promising form of antimicrobial therapeutics to combat invasive fungal diseases. Cytokine and chemokine profiles may also be applied as biomarkers during fungal infections and clinical research has demonstrated different activation patterns of cytokines in invasive mycoses such as aspergillosis. In this review, we summarize different aspects of cytokines that have been described to date and provide possible future directions in research on invasive pulmonary aspergillosis following hematopoietic stem cell transplantation. These findings suggest that cytokines and chemokines may serve as useful biomarkers to improve diagnosis and monitoring of infection.


2011 ◽  
Vol 3 (3) ◽  
pp. 18 ◽  
Author(s):  
Simone Cesaro ◽  
Marta Pillon ◽  
Elisabetta Calore ◽  
Rita Alaggio ◽  
Piergiorgio Gamba ◽  
...  

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 200%; text-align: justify;"><span style="mso-ansi-language: EN-GB; mso-bidi-font-weight: bold;" lang="EN-GB"><span style="font-size: small;"><span style="font-family: Times New Roman;">An 8-year old boy, affected by severe aplastic anemia, developed<span style="mso-spacerun: yes;"> </span>a probable pulmonary invasive aspergillosis (IA) early after a second unrelated allogeneic hematopoietic stem cell transplant (HSCT). He was treated promptly with the combination of liposomal amphotericin B and caspofungin. Despite the initial stabilization, the patient deteriorated and the antifungal therapy was switched to voriconazole and caspofungin. The patient gradually improved and was discharged home on day +29 post-HSCT on oral voriconazole. <span style="mso-spacerun: yes;"> </span>On day +119, a sudden episode of hemoptysis occurred and a right superior lobectomy was decided to remove the residual aspergilloma. The patient is now alive and well more than 24 months from HSCT. This case demonstrated that antifungal combination therapy and surgery are valid options to cure pulmonary IA even in patients at high-risk and severely immunosuppressed.<span style="mso-spacerun: yes;"> </span></span></span></span></p>


2007 ◽  
Vol 35 (4) ◽  
pp. 78-86 ◽  
Author(s):  
Hal E. Broxmeyer ◽  
Ji Li ◽  
Giao Hangoc ◽  
Scott Cooper ◽  
Wen Tao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document